Ping Kang

机构：University of Iowa, Iowa State University, Vertex Pharmaceuticals (United States)

发表论文 43 篇 · 总被引 1513 次 · h-index 22

代表论文

• Assessment of Three Human in Vitro Systems in the Generation of Major Human Excretory and Circulating Metabolites (2009 · Chemical Research in Toxicology · 被引 187)
• Pharmacokinetics, Distribution, and Metabolism of [14C]Sunitinib in Rats, Monkeys, and Humans (2011 · Drug Metabolism and Disposition · 被引 97)
• Selective Mechanism-Based Inactivation of CYP3A4 by CYP3cide (PF-04981517) and Its Utility as an In Vitro Tool for Delineating the Relative Roles of CYP3A4 versus CYP3A5 in the Metabolism of Drugs (2012 · Drug Metabolism and Disposition · 被引 90)
• Systematic Structure Modifications of Imidazo[1,2-a]pyrimidine to Reduce Metabolism Mediated by Aldehyde Oxidase (AO) (2011 · Journal of Medicinal Chemistry · 被引 82)
• Design, synthesis and biological evaluation of novel coumarin- N -benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease (2017 · European Journal of Medicinal Chemistry · 被引 75)
• Discovery of Aryloxy Tetramethylcyclobutanes as Novel Androgen Receptor Antagonists (2011 · Journal of Medicinal Chemistry · 被引 70)